Last reviewed · How we verify
NCT04498845: RECLEAN
RECLEAN Pilot Study
NA trial testing In-home assessment plan in Lead Poisoning in 35 participants. Terminated before completion.
20 January 2024
Quick facts
| Lead sponsor | Boston University |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 35 |
| Start date | 27 April 2021 |
| Primary completion | 20 January 2024 |
| Estimated completion | 20 January 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- In-home assessment plan
- Family educational session
- Worker take home prevention training
- D-LEAD cleaner products
Conditions studied
- Lead Poisoning — all drugs for Lead Poisoning →
Sponsor
Boston University
Who can join
1 and older, any sex, with Lead Poisoning. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is an exposure assessment pilot study tailored for families of construction workers living with a child. The investigators will compare home dust metal levels and resident's blood metal levels before and after an educational and environmental intervention. A baseline and a post intervention period assessment will be conducted with home and car lead inspections and risk assessments with collection of dust, urine, blood and toenail samples and a survey. Objectives of this research are to: 1. To characterize pre-intervention home exposures to lead and other metals in households with one construction worker inhabitant living with a child, by assessing household members' biospecimens and home dust metal levels. 2. To develop and evaluate customized home interventions (including environmental and educational approaches) to reduce metals exposure in three tiers of intervention. 3. To characterize home exposures to lead and other metals post intervention and determine adapted behaviors and whether the degree of metals exposure reduction (including take home exposures) in the households depends on the level of intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04498845
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Boston University trials
Trials by the same sponsor.
- NCT07199634 — Integrating U=U Into HIV Counseling in South Africa (INTUIT-2.0) · NA · not yet recruiting
- NCT05838378 — Cigarillo Warnings Image Sorting Study · NA · completed
- NCT06088277 — Texting to Reduce Human Immunodeficiency Virus (HIV) Risk · NA · recruiting
- NCT06455111 — Evaluation of an Artificial Intelligence-Assisted, Image-Based Dietary Assessment Tool in the Framingham Heart Study · NA · completed
- NCT06003439 — Vaping Prevention and Vaping in Youth (Vapechat) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04498845 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Boston University
- Last refreshed: 30 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04498845.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing